116 related articles for article (PubMed ID: 15073843)
21. Nuclear factor-kappaB dimer exchange promotes a p21(waf1/cip1) superinduction response in human T leukemic cells.
Chang PY; Miyamoto S
Mol Cancer Res; 2006 Feb; 4(2):101-12. PubMed ID: 16513841
[TBL] [Abstract][Full Text] [Related]
22. Nuclear factor-kappaB: the enemy within.
Aggarwal BB
Cancer Cell; 2004 Sep; 6(3):203-8. PubMed ID: 15380510
[TBL] [Abstract][Full Text] [Related]
23. Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha.
Lu ZG; Liu H; Yamaguchi T; Miki Y; Yoshida K
Cancer Res; 2009 Jul; 69(14):5927-35. PubMed ID: 19549902
[TBL] [Abstract][Full Text] [Related]
24. Distinct nuclear factor-kappaB/Rel proteins have opposing modulatory effects in glutamate-induced cell death in HT22 cells.
Ishige K; Tanaka M; Arakawa M; Saito H; Ito Y
Neurochem Int; 2005 Dec; 47(8):545-55. PubMed ID: 16183169
[TBL] [Abstract][Full Text] [Related]
25. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
[TBL] [Abstract][Full Text] [Related]
26. Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL.
Romagnoli M; Desplanques G; Maïga S; Legouill S; Dreano M; Bataille R; Barillé-Nion S
Clin Cancer Res; 2007 Oct; 13(20):6010-8. PubMed ID: 17947462
[TBL] [Abstract][Full Text] [Related]
27. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF
Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450
[TBL] [Abstract][Full Text] [Related]
28. Nuclear factor-kappaB-dependent mechanisms in breast cancer cells regulate tumor burden and osteolysis in bone.
Gordon AH; O'Keefe RJ; Schwarz EM; Rosier RN; Puzas JE
Cancer Res; 2005 Apr; 65(8):3209-17. PubMed ID: 15833852
[TBL] [Abstract][Full Text] [Related]
29. Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients.
Montagut C; Tusquets I; Ferrer B; Corominas JM; Bellosillo B; Campas C; Suarez M; Fabregat X; Campo E; Gascon P; Serrano S; Fernandez PL; Rovira A; Albanell J
Endocr Relat Cancer; 2006 Jun; 13(2):607-16. PubMed ID: 16728586
[TBL] [Abstract][Full Text] [Related]
30. Identification of novel mediators of NF-kappaB through genome-wide survey of monocyte adherence-induced genes.
Diatchenko L; Romanov S; Malinina I; Clarke J; Tchivilev I; Li X; Makarov SS
J Leukoc Biol; 2005 Dec; 78(6):1366-77. PubMed ID: 16204640
[TBL] [Abstract][Full Text] [Related]
31. The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy.
Wu JT; Kral JG
J Surg Res; 2005 Jan; 123(1):158-69. PubMed ID: 15652965
[TBL] [Abstract][Full Text] [Related]
32. The role of NF-kappaB in lymphoid malignancies.
Packham G
Br J Haematol; 2008 Oct; 143(1):3-15. PubMed ID: 18573107
[TBL] [Abstract][Full Text] [Related]
33. Transcription factor NF-κB inhibitors as single therapeutic agents or in combination with classical chemotherapeutic agents for the treatment of hematologic malignancies.
Fuchs O
Curr Mol Pharmacol; 2010 Nov; 3(3):98-122. PubMed ID: 20594187
[TBL] [Abstract][Full Text] [Related]
34. NF-κB signaling activation via increases in BRD2 and BRD4 confers resistance to the bromodomain inhibitor I-BET151 in U937 cells.
Hishiki K; Akiyama M; Kanegae Y; Ozaki K; Ohta M; Tsuchitani E; Kaito K; Yamada H
Leuk Res; 2018 Nov; 74():57-63. PubMed ID: 30300821
[TBL] [Abstract][Full Text] [Related]
35. Signaling from toxic metals to NF-kappaB and beyond: not just a matter of reactive oxygen species.
Chen F; Shi X
Environ Health Perspect; 2002 Oct; 110 Suppl 5(Suppl 5):807-11. PubMed ID: 12426136
[TBL] [Abstract][Full Text] [Related]
36. [Role of NF-kappaB in hematopoietic malignancies - review].
Chen C; Chen L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):954-9. PubMed ID: 18718099
[TBL] [Abstract][Full Text] [Related]
37. The role of NF-kappaB in the regulation of cell stress responses.
Wang T; Zhang X; Li JJ
Int Immunopharmacol; 2002 Oct; 2(11):1509-20. PubMed ID: 12433052
[TBL] [Abstract][Full Text] [Related]
38. NF-kappaB Signaling Pathways in Neurological Inflammation: A Mini Review.
Shih RH; Wang CY; Yang CM
Front Mol Neurosci; 2015; 8():77. PubMed ID: 26733801
[TBL] [Abstract][Full Text] [Related]
39. [Advances of study on activation of nuclear factor kappaB in hematological malignancies and its mechanism--review].
Wang GP; Qi ZH; Chen FP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):518-23. PubMed ID: 15972157
[TBL] [Abstract][Full Text] [Related]
40. NF-kappaB signaling proteins as therapeutic targets for inflammatory bowel diseases.
Jobin C; Sartor RB
Inflamm Bowel Dis; 2000 Aug; 6(3):206-13. PubMed ID: 10961593
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
